Mark Euwe
About Mark Euwe
Posts by Mark Euwe:
Gilbert is open for collaboration!
Gilbert is open for collaboration to redefine treatments for lung patients with an initial interest in improving inhaled anti-infective treatments.
Following our recent introduction at the SMI.London Conference on June 25th, we extend an invitation to Pharma, Biotech and Academia to collaborate and explore how electrospray can improve your inhaled therapy. The Gilbert team will work with you to optimize formulation and electrospray aerosol generation in our dedicated lab to ensure you reach your target.
Download our latest brochure ‘What’s your target?’ to learn more.
The brochure elaborates on the need for precision in pulmonary drug delivery, and the important role particle size and particle size distribution play. It presents how electrospray produces monodisperse droplets with customizable droplet size, enabling more precise targeting in the lungs. It also describes the unique Features & Benefits of the Gilbert Smart Precision Inhaler under development.
Interested to explore? Please contact us at info@gilbert.eu.
Let’s meet @ HLTH Europe Amsterdam
The Gilbert team will be visiting HLTH Europe 2024, coming 17-20 June in Amsterdam.
We look forward to connect with pharma and biotech decision makers to redefine treatment for lung patients together.
So if you are also visiting, let’s meet up in Amsterdam!
To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Maurits Huigen or Scott Fleming.
Just…. Gilbert !
We have changed our company brand from Gilbert Technologies to just ….. Gilbert!
This change reflects an underlying change in our legal structure, where Gilbert Innovation, Gilbert Therapeutics and Gilbert Technologies are now all subsidiaries of the Gilbert Group.
Our mission remains the same: Redefining treatment for lung patients
Please note that we changed our domain name to: Gilbert.eu
For any questions, please contact us at info@Gilbert.eu and/or follow us on Linkedin.
See you at SMI London on June 25th
The Gilbert team looks forward to exhibiting at SMI London on June 25th.
Join us at this 2nd Soft Mist Inhaler conference and learn to make, develop, use, file and launch Soft Mist Inhalers, and their place in an inhaled therapy portfolio.
Next to exhibiting, Gilbert is also happy to be a sponsor of this interesting event.
Do visit us at our location on the floor or contact us at info@Gilbert.eu, if you would like to schedule a meetup.
Visit the conference website here.
Gilbert is proud to sponsor ESEE2024
Gilbert is a proud sponsor of the 7th European Symposium on Electrohydrodynamic Atomization and Electrospinning 2024.
This year ESEE2024 is taking place in Leeuwarden, The Netherlands from April 24-26.
We look forward hearing about the latest developments in the field of:
– Fundamentals of electrohydrodynamic atomization (EHDA) processes
– Characterization of electrospraying and electrospinning processes
– Applications
Contact us at info@Gilbert.eu, if you would like to meetup.
Visit the conference website here.
About slide 3
From lab to prototype
In 2020 Gilbert advanced from the benchtop system to a functional, handheld prototype device. At the same time Gilbert’s team has been preparing the foundation for meeting the stringent requirements for medical devices. This will allow us to seamlessly develop a safe and effective, CE certifiable investigational device for clinical trial developments.
About slide 2
Proof-of-Concept
Years of research work at TU Delft, and later by Gilbert, have been dedicated to the demonstration of proof-of-concept of the electrospray technology for respiratory drug delivery and related formulation development for a variety of pharmaceutical compounds. This was successfully done initially on a large benchtop system.
About slide 1
Gilbert’s genesis
Gilbert B.V. (Gilbert) started as a spin-off of Delft University of Technology (TU Delft) where it pioneered the technology for an electrospray nebulizer.
Since 2020 Gilbert is based at the High Tech Campus in Eindhoven.
It’s Gilbert’s mission to make medical treatments easier and more effective for lung patients to extend and improve lives, as well as reduce the burden on the healthcare systems.